We are live on ! Find out more
AZN icon

AstraZeneca
AZN

331 hedge funds and large institutions have $5.84B invested in AstraZeneca in 2013 Q2 according to their latest regulatory filings, with 331 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

227% more call options, than puts

Call options by funds: $100M | Put options by funds: $30.6M

9.87% more ownership

Funds ownership: 0% → 9.87% (+9.9%)

Holders
331
Holders Change
+331
Holders Change %
–
% of All Funds
10.8%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.16%
New
331
Increased
–
Reduced
–
Closed
–
Calls
$100M
Puts
$30.6M
Net Calls
+$69.5M
Net Calls Change
+$69.5M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PSUF
151
People's United Financial
Connecticut
$1.24M +$1.33M +26,099 New
CA
152
Commerzbank Aktiengesellschaft
Germany
$1.22M +$1.31M +25,743 New
CK
153
Carnick & Kubik
Colorado
$1.22M +$1.31M +25,750 New
WMSA
154
Weiss Multi-Strategy Advisers
New York
$1.18M +$1.27M +25,000 New
Mirae Asset Global Investments
155
Mirae Asset Global Investments
South Korea
$1.17M +$1.26M +24,710 New
PAI
156
Pittenger & Anderson Inc
Nebraska
$1.17M +$1.26M +24,670 New
CPIM
157
Columbia Partners Investment Management
Virginia
$1.16M +$1.25M +24,492 New
Toronto Dominion Bank
158
Toronto Dominion Bank
Ontario, Canada
$1.07M +$1.15M +22,655 New
WTNA
159
Wilmington Trust National Association
Delaware
$1.06M +$1.14M +22,335 New
RHBC
160
R.H. Bluestein & Co
Michigan
$1.04M +$1.12M +22,000 New
JG
161
Jefferies Group
New York
$1.02M +$1.1M +21,643 New
SFP
162
Santa Fe Partners
New Mexico
$1.02M +$1.1M +21,507 New
Natixis Advisors
163
Natixis Advisors
Massachusetts
$1.01M +$1.09M +21,321 New
PSI
164
Pinnacle Summer Investments
Virginia
$1M +$1.08M +21,160 New
RBC
165
Ronald Blue & Co
Georgia
$979K +$1.05M +20,704 New
AIG
166
American International Group
New York
$972K +$1.05M +20,551 New
Janney Montgomery Scott
167
Janney Montgomery Scott
Pennsylvania
$971K +$1.05M +20,535 New
CA
168
Continental Advisors
Utah
$946K +$1.02M +20,000 New
B
169
BancorpSouth
Mississippi
$941K +$1.01M +19,891 New
HCM
170
Howland Capital Management
Massachusetts
$941K +$1.01M +19,901 New
ANTB
171
AMG National Trust Bank
Colorado
$937K +$1.01M +19,810 New
BJ
172
BlackRock Japan
Japan
$932K +$1M +19,700 New
HC
173
HHG & Company
Connecticut
$930K +$997K +19,585 New
LTFS
174
Ladenburg Thalmann Financial Services
Florida
$918K +$988K +19,393 New
RJT
175
Raymond James Trust
Florida
$810K +$872K +17,127 New
5 6
7
8 9

AZN Hedge Fund Activity: Q2 2013 in Review

331 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZN) for Q2 2013, worth a combined $5.84B.

Buyers outnumbered sellers: 331 funds opened new AZN positions and 0 closed out — a net gain of 331 holders — while 0 added to existing stakes and 0 trimmed.

  • 331 institutional investors held AstraZeneca (AZN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $5.84B of AstraZeneca stock for Q2 2013.
  • 331 funds opened new AstraZeneca positions in Q2 2013 and 0 closed out, a net change of +331 holders.

Based on aggregated 13F filings for Q2 2013.